Ipsen nominates Peter Guenter to Board of Directors
Ipsen has appointed Peter Guenter to its Board of Directors effective 28 January 2026. He fills the vacancy created by Henri Beaufour’s seat.
Novo Nordisk employees elect new board representatives
Novo Nordisk employees have elected new representatives to the Board of Directors. The new term starts after the AGM on 26 March 2026.
Essity appoints Niklas Westin Sundberg as Chief Digital & Information Officer
Essity names Niklas Westin Sundberg as CDIO, succeeding Carl-Magnus Månsson. He joins the Executive Management Team on April 15, 2026.
Bavarian Nordic: Paul Chaplin to step down as CEO
Bavarian Nordic says CEO Paul Chaplin will step down for personal reasons. He will stay through 2026 or until a successor is appointed.
medac appoints Dr. Christoph Willers as Chief Scientific Officer
The medac Group appoints Dr. Christoph Willers as CSO. He will lead research, clinical development and studies, plus pipeline and portfolio management.
SynAct Pharma appoints Ann Kristin Led as CFO
SynAct Pharma has named Ann Kristin Led as CFO, effective 1 March 2026. The finance executive brings experience across life sciences, pharma and med-tech.
Xspray Pharma appoints Blake Leitch as CEO, Per Andersson to become CSO
Xspray Pharma has appointed Blake Leitch as CEO, with the start date no later than June 1, 2026. Current CEO Per Andersson will become CSO.
Fresenius extends CEO Michael Sen’s contract to 2031, appoints Pawlu to the Management Board
Fresenius extends CEO Michael Sen’s contract early, taking it through 2031. Helios executive Christian Pawlu will join the Management Board on July 1, 2026.
Roche appoints Mark Dawson to lead pRED
Roche names Mark Dawson as Head of Pharma Research and Early Development from 1 May 2026 and adds him to the Enlarged Corporate Executive Committee.
L’Oréal appoints Julia Huhn to lead communications across DACH
Julia Huhn has led Communication & Public Affairs at L’Oréal DACH since 15 February. She succeeds Stefan Geister and joins from Santander.
Linda Maria Diodati appointed Managing Director at Thieme Media
Linda Maria Diodati became Managing Director of Thieme Media on 1 February 2026. She succeeds Oliver Fock, who moved into a staff role.
Biogen names Dr. Maria C. Freire as next board chair
Biogen will shift its board leadership: Dr. Maria C. Freire is set to become chair after the June 9, 2026 annual meeting.
Sanofi appoints Belén Garijo as new CEO
Sanofi has appointed Belén Garijo as CEO. Paul Hudson will leave on Feb. 17, 2026, with Olivier Charmeil serving as interim leader.
Engelhard strengthens strategic development with new CCSO role
Engelhard has created a Transformation Office and appointed Ann-Katrin Frank as Chief Commercial Strategy Officer to steer strategic development.
Daiichi Sankyo Appoints New Leadership for European Research Center
Daiichi Sankyo has appointed Dr. Veronika Rozehnal as the new Head of the Translational Research Center Europe. She succeeds Dr. Jürgen Müller, who is retiring after nearly 30 years of research service.
New employee representative on the Board of Directors of Novo Nordisk
After 22 years at Novo Nordisk, Thomas Rantzau steps down from the Board of Directors. His former alternate, Tanja Villumsen, assumes the role of employee representative with immediate effect.
Benjamin Hein Appointed Member of the Executive Board and CEO Electronics at Merck
Merck has appointed Benjamin Hein as a member of the Executive Board and CEO Electronics. The experienced executive will assume the role on May 1, 2026, succeeding Kai Beckmann.
Jonas Gehrling joins the management team of Serviceplan Content Health
As of January 1, 2026, Jonas Gehrling has joined the management team of Serviceplan Content Health. Together with Nadine van Maanen, he will lead the Berlin-based healthcare content agency.
Leadership Transition at Psyma+Exevia
Psyma+Exevia Health GmbH sets the course for the future: Heidi Lüttgens assumes management responsibility from Roland Herterich and Norbert Schell. The leadership transition combines continuity with new momentum for growth and innovation.
Florian Truckenbrodt takes over Sales and Marketing
As of February 1, 2026, Alliance Healthcare Germany will bundle Sales and Marketing under one leadership. Florian Truckenbrodt will be responsible for both areas to further strengthen pharmacies in the market.